Navigation Links
New guideline from ASH and ASCO recommends caution regarding ESA use in cancer patients
Date:10/26/2010

(WASHINGTON, October 25, 2010) An updated joint guideline by the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO) advises physicians about the appropriate use of erythropoiesis-stimulating agents (ESAs), a class of drugs that stimulate the bone marrow to produce more red blood cells, to treat cancer patients with chemotherapy-induced anemia. While the guideline cautions that ESAs are associated with shorter survival and increased risk of thromboembolism blood clots and tumor progression, it also recognizes their major benefit of reducing the need for red blood cell transfusions, which can potentially cause serious infections and adverse reactions in the immune system.

"This updated guideline offers clinicians the latest synthesis of the medical evidence surrounding use of ESAs in patients with cancer, including appropriate cautions where evidence is lacking or where risks may outweigh the use of ESAs," said J. Douglas Rizzo, MD, MS, Co-Chair of the guideline panel and Professor of Medicine at the Medical College of Wisconsin.

Those risks may include thromboembolism or even death, according to new data cited in the guideline, which suggests that physicians avoid the use of ESAs in cancer patients who are not receiving chemotherapy, except for those with myelodysplastic syndrome (MDS). At the same time, the guideline confirms the effectiveness of ESAs in sparing patients the need for transfusions, which can substantially impact quality of life. By recommending that physicians discuss individual risks and benefits of ESAs and blood transfusion with patients prior to therapy, the guideline recognizes the critical role of shared decision-making between the patient and the physician.

In addition to outlining the clotting risks of ESAs, the guideline makes specific recommendations on usage and provides insights into disease progression and patient survival. The guideline also details new threshold
'/>"/>

Contact: Lindsey Love
llove@hematology.org
202-552-4925
American Society of Hematology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Experts unveil new CVD guidelines and position papers at Canadian Cardiovascular Congress 2010
2. Pediatricians Issue New Iron Guidelines
3. UH Case Medical Center receives Get With The Guidelines Gold Plus Performance Achievement Award
4. New CPR Guidelines Emphasize Compressions First
5. Most Doctors Dont Follow Colon Cancer Screening Guidelines
6. OCTANE study influences revision of WHO guidelines for treating some HIV-infected women
7. Not all doctors follow cancer screening guidelines
8. New osteoporosis guidelines: Osteoporosis Canada
9. Mammogram Guidelines Still Beget Confusion
10. New Medicare model guidelines for benefit years 2012-2014 in development
11. Leading practitioners recommend global PTSD treatment guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 01, 2014 AMTC hosts and scout teams ... 1 p.m. in three cities on August 9. Professionals and ... to participate in the free auditions. , Since 1982, ... models, singers, dancers and comedians. Recently, AMTC grad Austen Williams ... to compete for Mrs. World in May 2014. She says ...
(Date:8/1/2014)... Fuel additives market is witnessing an increase ... Low Sulphur Diesel (ULSD), which requires more dosing of ... market for fuel additives. Globally, this market has been ... product innovation in terms of quality and application development. ... U.S. (the most dominant market, accounting largest market share), ...
(Date:8/1/2014)... 01, 2014 The European gas chromatography systems ... analysis and forecast of revenue. The gas chromatography systems market ... is estimated to grow to around $247.6 million by 2018, ... Browse through the TOC of the European gas chromatography systems ... This also provides a glimpse of the segmentation of gas ...
(Date:8/1/2014)... news release is available in German . ... the Substantia nigra brain region their mitochondrial activity ceases ... of Molecular Cell Biology and Genetics show that supplying D-lactate ... and even counteract this process: Adding the substances to cultured ... elegans restored the activity of mitochondria and prevented the ...
(Date:8/1/2014)... New Orleans, LA The Health Resources and ... Center New Orleans School of Nursing an Advanced ... over three years. The funding will support training ... of care for military veterans and diverse populations ... Laura Bonanno, DNP, CRNA, LSUHSC Nurse Anesthesia Program ...
Breaking Medicine News(10 mins):Health News:AMTC Announces Three Upcoming Audition Sites for Upcoming Performers 2Health News:North America Fuel Additives Market is Expected to Reach $2,269.6 Million in 2019 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $2,269.6 Million in 2019 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $2,269.6 Million in 2019 - New Report by MicroMarket Monitor 4Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:European Gas Chromatography (GC) Systems Market is Expected to Reach $247.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Potential treatment and prevention of Parkinson's disease 2Health News:LSUHSC Nursing awarded $1 million grant to improve care for veterans 2
... 6 May 2010 -- Researchers from Cold Spring Harbor Laboratory ... analyzing the genome of single tumor cells. The breakthrough allows ... tumors develop and has the potential to help doctors identify ... from the prostate or a non-invasive lesion in the breast. ...
... May 2010 -- A new study of metastatic breast ... patients have in their blood directly correlates with the ... Cancer Conference in Brussels, Belgium, the results have the ... these patients. Circulating tumor cells --cancer cells found ...
... After menopause, 6 to 10 million women take hormone ... progestin, to replace hormones lost from inactive ovaries. Progestin ... potentially negative effects of estrogen therapy on the uterus. ... evidence has been found that estrogen and progestin in ...
... ... , ... (PRWEB) May 6, 2010 -- CosmoCom the global leader in Contact Center Consolidation ... prestigious 2010 Long Island Software Award (LISA). Presented by the Long Island Software and ...
... ... steady employment in a highly competitive market. In order to gain a competitive edge against ... appearance. Non-surgical med spa treatments can offer many benefits during a job hunt. , ... (PRWEB) May 6, 2010 -- With ...
... ... achieving top performance from GPUs in diverse applications using Monte Carlo simulations can now ... Group (NAG). , ... (Vocus) May 6, 2010 -- Developers and researchers who are interested in achieving top ...
Cached Medicine News:Health News:Genome breakthrough allows scientists to identify and profile tumor cells from very small samples 2Health News:Survival in metastatic breast cancer directly linked to circulating tumor cells 2Health News:Breast cancer metastasis increases after estrogen and progestin hormone therapies, MU study finds 2Health News:CosmoCom Wins Software Award for CosmoHealth 2Health News:CosmoCom Wins Software Award for CosmoHealth 3Health News:Med Spa Treatments Become More Popular as Unemployment Rates Climb 2Health News:Med Spa Treatments Become More Popular as Unemployment Rates Climb 3Health News:More GPU Routines for Technical Research Now Available from Numerical Algorithms Group 2Health News:More GPU Routines for Technical Research Now Available from Numerical Algorithms Group 3
(Date:8/1/2014)... 1, 2014 Research and Markets ... "Global Medical Biosensors Market 2014-2018" report to ... Medical biosensors are used to ... detectors. These biosensors monitor health status, disease betterment, ... methods. They are cost-effective and user-friendly devices. Also, ...
(Date:8/1/2014)... PALO ALTO, Calif. , Aug. 1, 2014 /PRNewswire/ ... announced a partnership to expand awareness of proper nutritional ... CFChef Shares program. CFChef Shares will run from August ... CFChef program – an online resource for CF patients ... healthy diet by submitting recipes to the Chef4CF.com ...
(Date:8/1/2014)... 1, 2014 According to ... (Traditional Wound Closure, Anti infective), Basic (Films, Cleansing), Advanced ... Skin Substitutes), Pressure Relief Devices, NPWT) - Global ... Care Market is expected to reach $18.3 Billion ... at a CAGR of 3.2% from 2014 to ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3
... Western Blot analysis ... Blot Analyzer for many applications including the ... of infectious diseases such as viruses and ... screening of allergies and other application areas ...
... Antigen-Antibody Pens-Using a proprietary and patented technology, ... pens, called Antigen-Antibody pens-TM, that will allow ... membranes in any form or shape or ... helps to see antigen being written on ...
... the Antigen-Antibody Pens-Using a proprietary and patented ... fountain pens, called Antigen-Antibody pens-TM, that will ... blotting membranes in any form or shape ... dyes helps to see antigen being written ...
... the Antigen-Antibody Pens-Using a proprietary and patented ... fountain pens, called Antigen-Antibody pens-TM, that will ... blotting membranes in any form or shape ... dyes helps to see antigen being written ...
Medicine Products: